Bionik Laboratories Corp.
BNKL
$0.0001
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -4.95M | -5.29M | -11.20M | -11.34M | -10.41M |
| Total Depreciation and Amortization | 63.20K | 56.50K | 67.30K | 84.80K | 102.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 482.30K | 540.90K | 6.13M | 6.34M | 6.02M |
| Change in Net Operating Assets | 1.01M | 687.20K | 114.10K | 228.30K | 140.40K |
| Cash from Operations | -3.39M | -4.01M | -4.89M | -4.69M | -4.15M |
| Capital Expenditure | -8.80K | -8.00K | -19.70K | -12.50K | -12.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -215.00K | -215.00K | -215.00K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -223.80K | -223.00K | -234.70K | -12.50K | -12.50K |
| Total Debt Issued | 2.05M | 1.55M | 750.00K | 5.50M | 5.55M |
| Total Debt Repaid | -- | 1.40K | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.05M | 1.55M | 750.00K | 5.50M | 5.55M |
| Foreign Exchange rate Adjustments | -3.00K | -3.10K | -3.20K | -8.80K | -7.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.56M | -2.68M | -4.38M | 787.20K | 1.38M |
